Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Liver Diseases

  Free Subscription


Articles published in Eur Radiol

Retrieve available abstracts of 163 articles:
HTML format
Text format



Single Articles


    July 2018
  1. HUI SCN, Wong SKH, Ai Q, Yeung DKW, et al
    Observed changes in brown, white, hepatic and pancreatic fat after bariatric surgery: Evaluation with MRI.
    Eur Radiol. 2018 Jul 30. pii: 10.1007/s00330-018-5611.
    PubMed     Text format     Abstract available


  2. ICHIKAWA S, Motosugi U, Enomoto N, Onishi H, et al
    Magnetic resonance elastography can predict development of hepatocellular carcinoma with longitudinally acquired two-point data.
    Eur Radiol. 2018 Jul 24. pii: 10.1007/s00330-018-5640.
    PubMed     Text format     Abstract available


  3. KIM R, Kang TW, Cha DI, Song KD, et al
    Percutaneous cryoablation for perivascular hepatocellular carcinoma: Therapeutic efficacy and vascular complications.
    Eur Radiol. 2018 Jul 24. pii: 10.1007/s00330-018-5617.
    PubMed     Text format     Abstract available


  4. YU J, Wang X, Jiang M, Ma H, et al
    Comparison of transjugular intrahepatic portosystemic shunt (TIPS) alone and combined with embolisation for the management of cardiofundal varices: a retrospective study.
    Eur Radiol. 2018 Jul 23. pii: 10.1007/s00330-018-5645.
    PubMed     Text format     Abstract available


  5. WEI Y, Gao F, Wang M, Huang Z, et al
    Intravoxel incoherent motion diffusion-weighted imaging for assessment of histologic grade of hepatocellular carcinoma: comparison of three methods for positioning region of interest.
    Eur Radiol. 2018 Jul 19. pii: 10.1007/s00330-018-5638.
    PubMed     Text format     Abstract available


  6. PLAIKNER M, Kremser C, Zoller H, Steurer M, et al
    Does gadoxetate disodium affect MRE measurements in the delayed hepatobiliary phase?
    Eur Radiol. 2018 Jul 19. pii: 10.1007/s00330-018-5616.
    PubMed     Text format     Abstract available


  7. KELLER S, Sedlacik J, Schuler T, Buchert R, et al
    Prospective comparison of diffusion-weighted MRI and dynamic Gd-EOB-DTPA-enhanced MRI for detection and staging of hepatic fibrosis in primary sclerosing cholangitis.
    Eur Radiol. 2018 Jul 16. pii: 10.1007/s00330-018-5614.
    PubMed     Text format     Abstract available


  8. SEO N, Kim MS, Park MS, Choi JY, et al
    Optimal criteria for hepatocellular carcinoma diagnosis using CT in patients undergoing liver transplantation.
    Eur Radiol. 2018 Jul 4. pii: 10.1007/s00330-018-5557.
    PubMed     Text format     Abstract available


    June 2018
  9. JEON SK, Joo I, Lee DH, Lee SM, et al
    Combined hepatocellular cholangiocarcinoma: LI-RADS v2017 categorisation for differential diagnosis and prognostication on gadoxetic acid-enhanced MR imaging.
    Eur Radiol. 2018 Jun 28. pii: 10.1007/s00330-018-5605.
    PubMed     Text format     Abstract available


  10. WU LF, Rao SX, Xu PJ, Yang L, et al
    Pre-TACE kurtosis of ADCtotal derived from histogram analysis for diffusion-weighted imaging is the best independent predictor of prognosis in hepatocellular carcinoma.
    Eur Radiol. 2018 Jun 19. pii: 10.1007/s00330-018-5482.
    PubMed     Text format     Abstract available


  11. SONG JS, Choi EJ, Hwang SB, Hwang HP, et al
    LI-RADS v2014 categorization of hepatocellular carcinoma: Intraindividual comparison between gadopentetate dimeglumine-enhanced MRI and gadoxetic acid-enhanced MRI.
    Eur Radiol. 2018 Jun 19. pii: 10.1007/s00330-018-5559.
    PubMed     Text format     Abstract available


  12. REFAAT R, Basha MAA, Hassan MS, Hussein RS, et al
    Efficacy of contrast-enhanced FDG PET/CT in patients awaiting liver transplantation with rising alpha-fetoprotein after bridge therapy of hepatocellular carcinoma.
    Eur Radiol. 2018 Jun 12. pii: 10.1007/s00330-018-5425.
    PubMed     Text format     Abstract available


  13. SONG J, Ma Z, Huang J, Liu S, et al
    Comparison of three cut-offs to diagnose clinically significant portal hypertension by liver stiffness in chronic viral liver diseases: a meta-analysis.
    Eur Radiol. 2018 Jun 1. pii: 10.1007/s00330-018-5478.
    PubMed     Text format     Abstract available


    May 2018
  14. ASENBAUM U, Kaczirek K, Ba-Ssalamah A, Ringl H, et al
    Post-hepatectomy liver failure after major hepatic surgery: not only size matters.
    Eur Radiol. 2018 May 16. pii: 10.1007/s00330-018-5487.
    PubMed     Text format     Abstract available


  15. WINTER KS, Hofmann FO, Thierfelder KM, Holch JW, et al
    Towards volumetric thresholds in RECIST 1.1: Therapeutic response assessment in hepatic metastases.
    Eur Radiol. 2018 May 7. pii: 10.1007/s00330-018-5424.
    PubMed     Text format     Abstract available


  16. SIVESGAARD K, Larsen LP, Sorensen M, Kramer S, et al
    Diagnostic accuracy of CE-CT, MRI and FDG PET/CT for detecting colorectal cancer liver metastases in patients considered eligible for hepatic resection and/or local ablation.
    Eur Radiol. 2018 May 7. pii: 10.1007/s00330-018-5469.
    PubMed     Text format     Abstract available


  17. REIZINE E, Amaddeo G, Pigneur F, Baranes L, et al
    Quantitative correlation between uptake of Gd-BOPTA on hepatobiliary phase and tumor molecular features in patients with benign hepatocellular lesions.
    Eur Radiol. 2018 May 2. pii: 10.1007/s00330-018-5438.
    PubMed     Text format     Abstract available


    April 2018
  18. GETZIN T, Gueler F, Hartleben B, Gutberlet M, et al
    Gd-EOB-DTPA-enhanced MRI for quantitative assessment of liver organ damage after partial hepatic ischaemia reperfusion injury: correlation with histology and serum biomarkers of liver cell injury.
    Eur Radiol. 2018 Apr 30. pii: 10.1007/s00330-018-5380.
    PubMed     Text format     Abstract available


  19. ZHANG HX, Fu JF, Lai C, Tian FY, et al
    Feasibility of balanced steady-state free precession sequence at 1.5T for the evaluation of hepatic steatosis in obese children and adolescents.
    Eur Radiol. 2018 Apr 30. pii: 10.1007/s00330-018-5344.
    PubMed     Text format     Abstract available


  20. SCHELLHAAS B, Hammon M, Strobel D, Pfeifer L, et al
    Interobserver and intermodality agreement of standardized algorithms for non-invasive diagnosis of hepatocellular carcinoma in high-risk patients: CEUS-LI-RADS versus MRI-LI-RADS.
    Eur Radiol. 2018 Apr 19. pii: 10.1007/s00330-018-5379.
    PubMed     Text format     Abstract available


  21. AKAI H, Yasaka K, Kunimatsu A, Nojima M, et al
    The inhibitory effect of gadoxetate disodium on hepatic transporters: a study using indocyanine green.
    Eur Radiol. 2018 Apr 12. pii: 10.1007/s00330-018-5403.
    PubMed     Text format     Abstract available


  22. SANDRASEGARAN K, Cui E, Elkady R, Gasparis P, et al
    Can functional parameters from hepatobiliary phase of gadoxetate MRI predict clinical outcomes in patients with cirrhosis?
    Eur Radiol. 2018 Apr 12. pii: 10.1007/s00330-018-5366.
    PubMed     Text format     Abstract available


  23. TOVOLI F, Renzulli M, Negrini G, Brocchi S, et al
    Inter-operator variability and source of errors in tumour response assessment for hepatocellular carcinoma treated with sorafenib.
    Eur Radiol. 2018 Apr 9. pii: 10.1007/s00330-018-5393.
    PubMed     Text format     Abstract available


  24. KIM YS, Jang YN, Song JS
    Comparison of gradient-recalled echo and spin-echo echo-planar imaging MR elastography in staging liver fibrosis: a meta-analysis.
    Eur Radiol. 2018;28:1709-1718.
    PubMed     Text format     Abstract available


  25. LEE SJ, Zea R, Kim DH, Lubner MG, et al
    CT texture features of liver parenchyma for predicting development of metastatic disease and overall survival in patients with colorectal cancer.
    Eur Radiol. 2018;28:1520-1528.
    PubMed     Text format     Abstract available


  26. PEREIRA PL, Kruger K, Hohenstein E, Welke F, et al
    Intraprocedural 3D perfusion measurement during chemoembolisation with doxorubicin-eluting beads in liver metastases of malignant melanoma.
    Eur Radiol. 2018;28:1456-1464.
    PubMed     Text format     Abstract available


  27. SEMELKA RC, Nimojan N, Chandana S, Ramalho M, et al
    MRI features of primary rare malignancies of the liver: A report from four university centres.
    Eur Radiol. 2018;28:1529-1539.
    PubMed     Text format     Abstract available


  28. HWANG SM, Jeon TY, Yoo SY, Choe YH, et al
    Early US findings of biliary atresia in infants younger than 30 days.
    Eur Radiol. 2018;28:1771-1777.
    PubMed     Text format     Abstract available


  29. BROUHA SS, Nguyen P, Bettencourt R, Sirlin CB, et al
    Increased severity of liver fat content and liver fibrosis in non-alcoholic fatty liver disease correlate with epicardial fat volume in type 2 diabetes: A prospective study.
    Eur Radiol. 2018;28:1345-1355.
    PubMed     Text format     Abstract available


    March 2018
  30. LUO J, Li M, Zhang Y, Wang H, et al
    Percutaneous transhepatic intrahepatic portosystemic shunt for variceal bleeding with chronic portal vein occlusion after splenectomy.
    Eur Radiol. 2018 Mar 29. pii: 10.1007/s00330-018-5360.
    PubMed     Text format     Abstract available


  31. CHEN S, Peng Z, Lin M, Chen Z, et al
    Combined percutaneous radiofrequency ablation and ethanol injection versus hepatic resection for 2.1-5.0 cm solitary hepatocellular carcinoma: a retrospective comparative multicentre study.
    Eur Radiol. 2018 Mar 29. pii: 10.1007/s00330-018-5371.
    PubMed     Text format     Abstract available


  32. HEERINK WJ, Solouki AM, Vliegenthart R, Ruiter SJS, et al
    The relationship between applied energy and ablation zone volume in patients with hepatocellular carcinoma and colorectal liver metastasis.
    Eur Radiol. 2018 Mar 13. pii: 10.1007/s00330-017-5266.
    PubMed     Text format     Abstract available


  33. PENG Z, Wei M, Chen S, Lin M, et al
    Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study.
    Eur Radiol. 2018 Mar 13. pii: 10.1007/s00330-017-5166.
    PubMed     Text format     Abstract available


  34. SONG JS, Choi EJ, Park EH, Lee JH, et al
    Comparison of transient severe motion in gadoxetate disodium and gadopentetate dimeglumine-enhanced MRI: effect of modified breath-holding method.
    Eur Radiol. 2018;28:1132-1139.
    PubMed     Text format     Abstract available


  35. BRAAT AJAT, Prince JF, van Rooij R, Bruijnen RCG, et al
    Safety analysis of holmium-166 microsphere scout dose imaging during radioembolisation work-up: A cohort study.
    Eur Radiol. 2018;28:920-928.
    PubMed     Text format     Abstract available


  36. KIM JR, Suh CH, Yoon HM, Lee JS, et al
    The diagnostic performance of shear-wave elastography for liver fibrosis in children and adolescents: A systematic review and diagnostic meta-analysis.
    Eur Radiol. 2018;28:1175-1186.
    PubMed     Text format     Abstract available


    February 2018
  37. DE CECCO CN, Caruso D, Schoepf UJ, De Santis D, et al
    A noise-optimized virtual monoenergetic reconstruction algorithm improves the diagnostic accuracy of late hepatic arterial phase dual-energy CT for the detection of hypervascular liver lesions.
    Eur Radiol. 2018 Feb 19. pii: 10.1007/s00330-018-5313.
    PubMed     Text format     Abstract available


  38. LUO X, Wang X, Yu J, Zhu Y, et al
    Transjugular intrahepatic portosystemic shunt creation: three-dimensional roadmap versus CO2 wedged hepatic venography.
    Eur Radiol. 2018 Feb 19. pii: 10.1007/s00330-018-5316.
    PubMed     Text format     Abstract available


  39. NAGANAWA S, Enooku K, Tateishi R, Akai H, et al
    Imaging prediction of nonalcoholic steatohepatitis using computed tomography texture analysis.
    Eur Radiol. 2018 Feb 5. pii: 10.1007/s00330-017-5270.
    PubMed     Text format     Abstract available


  40. AKAI H, Yasaka K, Nojima M, Kunimatsu A, et al
    Gadoxetate disodium-induced tachypnoea and the effect of dilution method: a proof-of-concept study in mice.
    Eur Radiol. 2018;28:692-697.
    PubMed     Text format     Abstract available


    January 2018
  41. NAJMI VARZANEH F, Pandey A, Aliyari Ghasabeh M, Shao N, et al
    Prediction of post-TACE necrosis of hepatocellular carcinoma usingvolumetric enhancement on MRI and volumetric oil deposition on CT, with pathological correlation.
    Eur Radiol. 2018 Jan 30. pii: 10.1007/s00330-017-5198.
    PubMed     Text format     Abstract available


  42. CIOLINA M, Di Martino M, Bruno O, Pommier R, et al
    Peritoneal and pleural fluids may appear hyperintense on hepatobiliary phase using hepatobiliary MR contrast agents.
    Eur Radiol. 2018 Jan 26. pii: 10.1007/s00330-017-5261.
    PubMed     Text format     Abstract available


  43. BASHA MAA, AlAzzazy MZ, Ahmed AF, Yousef HY, et al
    Does a combined CT and MRI protocol enhance the diagnostic efficacy of LI-RADS in the categorization of hepatic observations? A prospective comparative study.
    Eur Radiol. 2018 Jan 24. pii: 10.1007/s00330-017-5232.
    PubMed     Text format     Abstract available


  44. MIN JH, Kang TW, Kim YK, Kim SH, et al
    Hepatic neuroendocrine tumour: Apparent diffusion coefficient as a potential marker of prognosis associated with tumour grade and overall survival.
    Eur Radiol. 2018 Jan 24. pii: 10.1007/s00330-017-5248.
    PubMed     Text format     Abstract available


  45. CHOI SY, Kim YK, Min JH, Kang TW, et al
    Added value of ancillary imaging features for differentiating scirrhous hepatocellular carcinoma from intrahepatic cholangiocarcinoma on gadoxetic acid-enhanced MR imaging.
    Eur Radiol. 2018 Jan 15. pii: 10.1007/s00330-017-5196.
    PubMed     Text format     Abstract available


  46. WIJNANDS TFM, Gevers TJG, Lantinga MA, Te Morsche RH, et al
    Pasireotide does not improve efficacy of aspiration sclerotherapy in patients with large hepatic cysts, a randomized controlled trial.
    Eur Radiol. 2018 Jan 9. pii: 10.1007/s00330-017-5205.
    PubMed     Text format     Abstract available


  47. PARK JE, Choi YH, Cheon JE, Kim WS, et al
    Gallbladder wall oedema and ascites are independent predictors of progression to hepatic veno-occlusive disease for children with hematopoietic stem cell transplantation.
    Eur Radiol. 2018 Jan 2. pii: 10.1007/s00330-017-5137.
    PubMed     Text format     Abstract available


    December 2017
  48. LEWIS S, Besa C, Wagner M, Jhaveri K, et al
    Prediction of the histopathologic findings of intrahepatic cholangiocarcinoma: qualitative and quantitative assessment of diffusion-weighted imaging.
    Eur Radiol. 2017 Dec 12. pii: 10.1007/s00330-017-5156.
    PubMed     Text format     Abstract available


  49. PARK SH, Lee SS, Sung JY, Na K, et al
    Noninvasive assessment of hepatic sinusoidal obstructive syndrome using acoustic radiation force impulse elastography imaging: A proof-of-concept study in rat models.
    Eur Radiol. 2017 Dec 7. pii: 10.1007/s00330-017-5179.
    PubMed     Text format     Abstract available


  50. CHOI JW, Chung JW, Lee DH, Kim HC, et al
    Portal hypertension is associated with poor outcome of transarterial chemoembolization in patients with hepatocellular carcinoma.
    Eur Radiol. 2017 Dec 7. pii: 10.1007/s00330-017-5145.
    PubMed     Text format     Abstract available


  51. MINAMI Y, Minami T, Hagiwara S, Ida H, et al
    Ultrasound-ultrasound image overlay fusion improves real-time control of radiofrequency ablation margin in the treatment of hepatocellular carcinoma.
    Eur Radiol. 2017 Dec 1. pii: 10.1007/s00330-017-5162.
    PubMed     Text format     Abstract available


    November 2017
  52. MULE S, Pigneur F, Quelever R, Tenenhaus A, et al
    Can dual-energy CT replace perfusion CT for the functional evaluation of advanced hepatocellular carcinoma?
    Eur Radiol. 2017 Nov 22. doi: 10.1007/s00330-017-5151.
    PubMed     Text format     Abstract available


  53. LEE SE, An C, Hwang SH, Choi JY, et al
    Extracellular contrast agent-enhanced MRI: 15-min delayed phase may improve the diagnostic performance for hepatocellular carcinoma in patients with chronic liver disease.
    Eur Radiol. 2017 Nov 13. doi: 10.1007/s00330-017-5119.
    PubMed     Text format     Abstract available


  54. PARK J, Kim HC, Lee JH, Cho E, et al
    Chemoembolisation for hepatocellular carcinoma with bile duct invasion: is preprocedural biliary drainage mandatory?
    Eur Radiol. 2017 Nov 9. doi: 10.1007/s00330-017-5110.
    PubMed     Text format     Abstract available


    October 2017
  55. NAGAYAMA Y, Nakaura T, Oda S, Utsunomiya D, et al
    Dual-layer DECT for multiphasic hepatic CT with 50 percent iodine load: a matched-pair comparison with a 120 kVp protocol.
    Eur Radiol. 2017 Oct 23. doi: 10.1007/s00330-017-5114.
    PubMed     Text format     Abstract available


  56. PARK CJ, An C, Park S, Choi JY, et al
    Management of subcentimetre arterially enhancing and hepatobiliary hypointense lesions on gadoxetic acid-enhanced MRI in patients at risk for HCC.
    Eur Radiol. 2017 Oct 23. doi: 10.1007/s00330-017-5088.
    PubMed     Text format     Abstract available


    September 2017
  57. RENZULLI M, Buonfiglioli F, Conti F, Brocchi S, et al
    Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis.
    Eur Radiol. 2017 Sep 11. doi: 10.1007/s00330-017-5033.
    PubMed     Text format     Abstract available


  58. FANG J, Ma X, Yu D, Ma X, et al
    Specific imaging characteristic of solitary necrotic nodule of the liver: Marked peripheral rim-like enhancement with internal hypointensity on longer delayed MRI.
    Eur Radiol. 2017;27:3563-3573.
    PubMed     Text format     Abstract available


    August 2017
  59. HU H, Han H, Han XK, Wang WP, et al
    Nomogram for individualised prediction of liver failure risk after hepatectomy in patients with resectable hepatocellular carcinoma: the evidence from ultrasound data.
    Eur Radiol. 2017 Aug 4. doi: 10.1007/s00330-017-4900.
    PubMed     Text format     Abstract available


  60. GUIU B, Quenet F, Escal L, Bibeau F, et al
    Extended liver venous deprivation before major hepatectomy induces marked and very rapid increase in future liver remnant function.
    Eur Radiol. 2017;27:3343-3352.
    PubMed     Text format     Abstract available


  61. CHUNG MS, Kim HS, Lim YS, Jeon SB, et al
    Clinical impact of preoperative brain MR angiography and MR imaging in candidates for liver transplantation: a propensity score-matching study in a single institution.
    Eur Radiol. 2017;27:3532-3541.
    PubMed     Text format     Abstract available


  62. SOMERS I, Bipat S
    Contrast-enhanced CT in determining resectability in patients with pancreatic carcinoma: a meta-analysis of the positive predictive values of CT.
    Eur Radiol. 2017;27:3408-3435.
    PubMed     Text format     Abstract available


  63. ZHOU LY, Jiang H, Shan QY, Chen D, et al
    Liver stiffness measurements with supersonic shear wave elastography in the diagnosis of biliary atresia: a comparative study with grey-scale US.
    Eur Radiol. 2017;27:3474-3484.
    PubMed     Text format     Abstract available


    July 2017
  64. ZHU Y, Chen J, Kong W, Mao L, et al
    Predicting IDH mutation status of intrahepatic cholangiocarcinomas based on contrast-enhanced CT features.
    Eur Radiol. 2017 Jul 27. doi: 10.1007/s00330-017-4957.
    PubMed     Text format     Abstract available


  65. LEE S, Kim JH, Lee JH, Lee JH, et al
    Non-invasive monitoring of the therapeutic response in sorafenib-treated hepatocellular carcinoma based on photoacoustic imaging.
    Eur Radiol. 2017 Jul 27. doi: 10.1007/s00330-017-4960.
    PubMed     Text format     Abstract available


  66. SUH CH, Kim KW, Park SH, Shin S, et al
    A cost-effectiveness analysis of the diagnostic strategies for differentiating focal nodular hyperplasia from hepatocellular adenoma.
    Eur Radiol. 2017 Jul 19. doi: 10.1007/s00330-017-4967.
    PubMed     Text format     Abstract available


  67. HAMIE QM, Kobe AR, Mietzsch L, Manhart M, et al
    Prototype metal artefact reduction algorithm in flat panel computed tomography - evaluation in patients undergoing transarterial hepatic radioembolisation.
    Eur Radiol. 2017 Jul 14. doi: 10.1007/s00330-017-4946.
    PubMed     Text format     Abstract available


  68. GEISEL D, Raabe P, Ludemann L, Malinowski M, et al
    Gd-EOB-DTPA-enhanced MRI for monitoring future liver remnant function after portal vein embolization and extended hemihepatectomy: A prospective trial.
    Eur Radiol. 2017;27:3080-3087.
    PubMed     Text format     Abstract available


  69. NAKAMOTO A, Tanaka Y, Juri H, Nakai G, et al
    Diagnostic performance of reduced-dose CT with a hybrid iterative reconstruction algorithm for the detection of hypervascular liver lesions: a phantom study.
    Eur Radiol. 2017;27:2995-3003.
    PubMed     Text format     Abstract available


  70. KIM SS, Song KD, Kim YK, Kim HC, et al
    Disappearing or residual tiny (</=5 mm) colorectal liver metastases after chemotherapy on gadoxetic acid-enhanced liver MRI and diffusion-weighted imaging: Is local treatment required?
    Eur Radiol. 2017;27:3088-3096.
    PubMed     Text format     Abstract available


    June 2017
  71. CHEN HJ, Shi HB, Jiang LF, Li L, et al
    Disrupted topological organization of brain structural network associated with prior overt hepatic encephalopathy in cirrhotic patients.
    Eur Radiol. 2017 Jun 30. doi: 10.1007/s00330-017-4887.
    PubMed     Text format     Abstract available


  72. FRYDRYCHOWICZ A, Roldan-Alzate A, Winslow E, Consigny D, et al
    Comparison of radial 4D Flow-MRI with perivascular ultrasound to quantify blood flow in the abdomen and introduction of a porcine model of pre-hepatic portal hypertension.
    Eur Radiol. 2017 Jun 27. doi: 10.1007/s00330-017-4862.
    PubMed     Text format     Abstract available


  73. JUNG C, Groth M, Petersen KU, Hammel A, et al
    Hepatic shear wave elastography in children under free-breathing and breath-hold conditions.
    Eur Radiol. 2017 Jun 20. doi: 10.1007/s00330-017-4909.
    PubMed     Text format     Abstract available


  74. LEE BC, Liu KL, Lin CL, Kao CH, et al
    Risk of acute kidney injury after transarterial chemoembolisation in hepatocellular carcinoma patients: A nationwide population-based cohort study.
    Eur Radiol. 2017 Jun 7. doi: 10.1007/s00330-017-4893.
    PubMed     Text format     Abstract available


  75. DIPAOLA FW, Schumacher KR, Goldberg CS, Friedland-Little J, et al
    Effect of Fontan operation on liver stiffness in children with single ventricle physiology.
    Eur Radiol. 2017;27:2434-2442.
    PubMed     Text format     Abstract available


    May 2017
  76. ZHENG G, Lu H, Yu W, Luo S, et al
    Severity-specific alterations in CBF, OEF and CMRO2 in cirrhotic patients with hepatic encephalopathy.
    Eur Radiol. 2017 May 18. doi: 10.1007/s00330-017-4809.
    PubMed     Text format     Abstract available


  77. HWANG J, Kim YK, Min JH, Choi SY, et al
    Capsule, septum, and T2 hyperintense foci for differentiation between large hepatocellular carcinoma (>/=5 cm) and intrahepatic cholangiocarcinoma on gadoxetic acid MRI.
    Eur Radiol. 2017 May 12. doi: 10.1007/s00330-017-4846.
    PubMed     Text format     Abstract available


  78. POOLER BD, Lubner MG, Kim DH, Chen OT, et al
    Prospective Evaluation of Reduced Dose Computed Tomography for the Detection of Low-Contrast Liver Lesions: Direct Comparison with Concurrent Standard Dose Imaging.
    Eur Radiol. 2017;27:2055-2066.
    PubMed     Text format     Abstract available


  79. YU J, Xu Q, Huang DY, Song JC, et al
    Prognostic aspects of dynamic contrast-enhanced magnetic resonance imaging in synchronous distant metastatic rectal cancer.
    Eur Radiol. 2017;27:1840-1847.
    PubMed     Text format     Abstract available


  80. KOOB M, Pariente D, Habes D, Ducot B, et al
    The porta hepatis microcyst: an additional sonographic sign for the diagnosis of biliary atresia.
    Eur Radiol. 2017;27:1812-1821.
    PubMed     Text format     Abstract available


    April 2017
  81. TAOULI B, Hoshida Y, Kakite S, Chen X, et al
    Imaging-based surrogate markers of transcriptome subclasses and signatures in hepatocellular carcinoma: preliminary results.
    Eur Radiol. 2017 Apr 24. doi: 10.1007/s00330-017-4844.
    PubMed     Text format     Abstract available


  82. WOO JH, Song KD, Kim SH
    Subcentimeter hypervascular nodules with typical imaging findings of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: Outcomes of early treatment and watchful waiting.
    Eur Radiol. 2017 Apr 6. doi: 10.1007/s00330-017-4818.
    PubMed     Text format     Abstract available


  83. HERATH NI, Devun F, Herbette A, Lienafa MC, et al
    Potentiation of doxorubicin efficacy in hepatocellular carcinoma by the DNA repair inhibitor DT01 in preclinical models.
    Eur Radiol. 2017 Apr 3. doi: 10.1007/s00330-017-4792.
    PubMed     Text format     Abstract available


    March 2017
  84. CHOI SY, Kim YK, Min JH, Cha DI, et al
    The value of gadoxetic acid-enhanced MRI for differentiation between hepatic microabscesses and metastases in patients with periampullary cancer.
    Eur Radiol. 2017 Mar 24. doi: 10.1007/s00330-017-4782.
    PubMed     Text format     Abstract available


  85. TALAKIC E, Schaffellner S, Kniepeiss D, Mueller H, et al
    CT perfusion imaging of the liver and the spleen in patients with cirrhosis: Is there a correlation between perfusion and portal venous hypertension?
    Eur Radiol. 2017 Mar 20. doi: 10.1007/s00330-017-4788.
    PubMed     Text format     Abstract available


  86. WEISS J, Taron J, Othman AE, Grimm R, et al
    Feasibility of self-gated isotropic radial late-phase MR imaging of the liver.
    Eur Radiol. 2017;27:985-994.
    PubMed     Text format     Abstract available


  87. LI WD, Yu HY, Qian AM, Rong JJ, et al
    Risk factors for and causes and treatment of recurrence of inferior vena cava type of Budd-Chiari syndrome after stenting in China: A retrospective analysis of a large cohort.
    Eur Radiol. 2017;27:1227-1237.
    PubMed     Text format     Abstract available


  88. LV P, Liu J, Yan X, Chai Y, et al
    CT spectral imaging for monitoring the therapeutic efficacy of VEGF receptor kinase inhibitor AG-013736 in rabbit VX2 liver tumours.
    Eur Radiol. 2017;27:918-926.
    PubMed     Text format     Abstract available


  89. SCHMEEL FC, Simon B, Sabet A, Luetkens JA, et al
    Diffusion-weighted magnetic resonance imaging predicts survival in patients with liver-predominant metastatic colorectal cancer shortly after selective internal radiation therapy.
    Eur Radiol. 2017;27:966-975.
    PubMed     Text format     Abstract available


    February 2017
  90. XU Y, Shen Q, Liu P, Xu Z, et al
    Microwave ablation for the treatment of hepatocellular carcinoma that met up-to-seven criteria: feasibility, local efficacy and long-term outcomes.
    Eur Radiol. 2017 Feb 10. doi: 10.1007/s00330-017-4740.
    PubMed     Text format     Abstract available


  91. KIM TH, Kim SH, Lee KB, Han JK, et al
    Outcome and CT differentiation of gallbladder neuroendocrine tumours from adenocarcinomas.
    Eur Radiol. 2017;27:507-517.
    PubMed     Text format     Abstract available


    January 2017
  92. BANNAS P, Bookwalter CA, Ziemlewicz T, Motosugi U, et al
    Combined gadoxetic acid and gadofosveset enhanced liver MRI for detection and characterization of liver metastases.
    Eur Radiol. 2017;27:32-40.
    PubMed     Text format     Abstract available


  93. VAN DEN HOVEN AF, Braat MN, Prince JF, van Doormaal PJ, et al
    Liver CT for vascular mapping during radioembolisation workup: comparison of an early and late arterial phase protocol.
    Eur Radiol. 2017;27:61-69.
    PubMed     Text format     Abstract available


  94. JAKOBS TF, Paprottka KJ, Raessler F, Strobl F, et al
    Robust evidence for long-term survival with 90Y radioembolization in chemorefractory liver-predominant metastatic colorectal cancer.
    Eur Radiol. 2017;27:113-119.
    PubMed     Text format     Abstract available


    December 2016
  95. CHEN BB, Hsu CY, Yu CW, Liang PC, et al
    Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  96. KIM M, Kang TW, Jeong WK, Kim YK, et al
    Gadoxetic acid-enhanced magnetic resonance imaging characteristics of hepatocellular carcinoma occurring in liver transplants.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  97. SOFUE K, Yoshikawa T, Ohno Y, Negi N, et al
    Improved image quality in abdominal CT in patients who underwent treatment for hepatocellular carcinoma with small metal implants using a raw data-based metal artifact reduction algorithm.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  98. VILGRAIN V, Esvan M, Ronot M, Caumont-Prim A, et al
    A meta-analysis of diffusion-weighted and gadoxetic acid-enhanced MR imaging for the detection of liver metastases.
    Eur Radiol. 2016;26:4595-4615.
    PubMed     Text format     Abstract available


    November 2016
  99. PICKHARDT PJ, Malecki K, Hunt OF, Beaumont C, et al
    Hepatosplenic volumetric assessment at MDCT for staging liver fibrosis.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  100. ZECH CJ, Justo N, Lang A, Ba-Ssalamah A, et al
    Cost evaluation of gadoxetic acid-enhanced magnetic resonance imaging in the diagnosis of colorectal-cancer metastasis in the liver: Results from the VALUE Trial.
    Eur Radiol. 2016;26:4121-4130.
    PubMed     Text format     Abstract available


  101. ROUSSET P, Gregory J, Rousset-Jablonski C, Hugon-Rodin J, et al
    MR diagnosis of diaphragmatic endometriosis.
    Eur Radiol. 2016;26:3968-3977.
    PubMed     Text format     Abstract available


    October 2016
  102. AN C, Rhee H, Han K, Choi JY, et al
    Added value of smooth hypointense rim in the hepatobiliary phase of gadoxetic acid-enhanced MRI in identifying tumour capsule and diagnosing hepatocellular carcinoma.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  103. COSTA AF, Atri M
    Reply to Letter to the Editor re: Should fat in the radiofrequency ablation zone of hepatocellular adenomas raise suspicion for residual tumour?
    Eur Radiol. 2016.
    PubMed     Text format    


  104. RONOT M, Benzimra J, Bouda D, Vilgrain V, et al
    Letter to the Editor re: Should fat in the radiofrequency ablation zone of hepatocellular adenomas raise suspicion for residual tumour?
    Eur Radiol. 2016.
    PubMed     Text format    


  105. GHOLAMREZANEZHAD A, Mirpour S, Geschwind JF, Rao P, et al
    Evaluation of 70-150-mum doxorubicin-eluting beads for transcatheter arterial chemoembolization in the rabbit liver VX2 tumour model.
    Eur Radiol. 2016;26:3474-82.
    PubMed     Text format     Abstract available


    September 2016
  106. SUGIHARA F, Murata S, Ueda T, Yasui D, et al
    Haemodynamic changes in hepatocellular carcinoma and liver parenchyma under balloon occlusion of the hepatic artery.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  107. FANG KC, Su CW, Chiou YY, Lee PC, et al
    The impact of clinically significant portal hypertension on the prognosis of patients with hepatocellular carcinoma after radiofrequency ablation: a propensity score matching analysis.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  108. GEEROMS B, Laleman W, Laenen A, Heye S, et al
    Expanded polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunts in cirrhotic patients: Long-term patency and clinical outcome results.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  109. KIM B, Kim KW, Kim SY, Park SH, et al
    Coronal 2D MR cholangiography overestimates the length of the right hepatic duct in liver transplantation donors.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  110. PARK HJ, Jang KM, Kang TW, Song KD, et al
    Identification of Imaging Predictors Discriminating Different Primary Liver Tumours in Patients with Chronic Liver Disease on Gadoxetic Acid-enhanced MRI: a Classification Tree Analysis.
    Eur Radiol. 2016;26:3102-11.
    PubMed     Text format     Abstract available


  111. RONOT M, Kerbaol A, Rautou PE, Brancatelli G, et al
    Acute extrahepatic infectious or inflammatory diseases are a cause of transient mosaic pattern on CT and MR imaging related to sinusoidal dilatation of the liver.
    Eur Radiol. 2016;26:3094-101.
    PubMed     Text format     Abstract available


  112. FU Y, Peng HJ, Zhang X, Peng WJ, et al
    Assessment of fibrotic tissue and microvascular architecture by in-line phase-contrast imaging in a mouse model of liver fibrosis.
    Eur Radiol. 2016;26:2947-55.
    PubMed     Text format     Abstract available


  113. THAISS WM, Haberland U, Kaufmann S, Spira D, et al
    Iodine concentration as a perfusion surrogate marker in oncology: Further elucidation of the underlying mechanisms using Volume Perfusion CT with 80 kVp.
    Eur Radiol. 2016;26:2929-36.
    PubMed     Text format     Abstract available


    August 2016
  114. LUDWIG JM, Zhang D, Xing M, Kim HS, et al
    Meta-analysis: adjusted indirect comparison of drug-eluting bead transarterial chemoembolization versus 90Y-radioembolization for hepatocellular carcinoma.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  115. MIRAGLIA R, Gerasia R, Maruzzelli L, D'Amico M, et al
    Radiation doses to operators performing transjugular intrahepatic portosystemic shunt using a flat-panel detector-based system and ultrasound guidance for portal vein targeting.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  116. HOFFMANN R, Rempp H, Kessler DE, Weiss J, et al
    MR-guided microwave ablation in hepatic tumours: initial results in clinical routine.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  117. GIRAUDEAU C, Leporq B, Doblas S, Lagadec M, et al
    Gadoxetate-enhanced MR imaging and compartmental modelling to assess hepatocyte bidirectional transport function in rats with advanced liver fibrosis.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  118. CHOI JW, Kim HC, Lee JH, Yu SJ, et al
    Transarterial chemoembolization of hepatocellular carcinoma with segmental portal vein tumour thrombus.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  119. HUR S, Chung JW, Zhou CG, Lee JH, et al
    Arteries of the falciform ligament on C-arm CT hepatic arteriography: The hepatic falciform artery and the Sappey's superior artery.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  120. ZHANG W, Chen HJ, Wang ZJ, Huang W, et al
    Dynamic contrast enhanced MR imaging for evaluation of angiogenesis of hepatocellular nodules in liver cirrhosis in N-nitrosodiethylamine induced rat model.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  121. MOCHE M, Heinig S, Garnov N, Fuchs J, et al
    Navigated MRI-guided liver biopsies in a closed-bore scanner: experience in 52 patients.
    Eur Radiol. 2016;26:2462-70.
    PubMed     Text format     Abstract available


  122. PIEPER CC, Willinek WA, Thomas D, Ahmadzadehfar H, et al
    Incidence and risk factors of early arterial blood flow stasis during first radioembolization of primary and secondary liver malignancy using resin microspheres: an initial single-center analysis.
    Eur Radiol. 2016;26:2779-89.
    PubMed     Text format     Abstract available


    July 2016
  123. LEE DH, Lee JM, Yi NJ, Lee KW, et al
    Hepatic stiffness measurement by using MR elastography: prognostic values after hepatic resection for hepatocellular carcinoma.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  124. COSTA AF, Kajal D, Pereira A, Atri M, et al
    Should fat in the radiofrequency ablation zone of hepatocellular adenomas raise suspicion for residual tumour?
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  125. MONIER A, Guiu B, Duran R, Aho S, et al
    Liver and biliary damages following transarterial chemoembolization of hepatocellular carcinoma: comparison between drug-eluting beads and lipiodol emulsion.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  126. FISCHER MA, Marquez HP, Gordic S, Leidner B, et al
    Arterio-portal shunts in the cirrhotic liver: perfusion computed tomography for distinction of arterialized pseudolesions from hepatocellular carcinoma.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


    June 2016
  127. KUMAR G, Goldberg SN, Wang Y, Velez E, et al
    Hepatic radiofrequency ablation: markedly reduced systemic effects by modulating periablational inflammation via cyclooxygenase-2 inhibition.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  128. GORODETSKI B, Chapiro J, Schernthaner R, Duran R, et al
    Advanced-stage hepatocellular carcinoma with portal vein thrombosis: conventional versus drug-eluting beads transcatheter arterial chemoembolization.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  129. SANO K, Ichikawa T, Motosugi U, Ichikawa S, et al
    Outcome of hypovascular hepatic nodules with positive uptake of gadoxetic acid in patients with cirrhosis.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  130. GROZINGER G, Mann S, Mehra T, Klumpp B, et al
    Metastatic patterns and metastatic sites in mucosal melanoma: a retrospective study.
    Eur Radiol. 2016;26:1826-34.
    PubMed     Text format     Abstract available


  131. CHEN SZ, Yuan J, Deng M, Wei J, et al
    Chemical exchange saturation transfer (CEST) MR technique for in-vivo liver imaging at 3.0 tesla.
    Eur Radiol. 2016;26:1792-800.
    PubMed     Text format     Abstract available


    May 2016
  132. TAGUCHI N, Oda S, Utsunomiya D, Funama Y, et al
    Using 80 kVp on a 320-row scanner for hepatic multiphasic CT reduces the contrast dose by 50 % in patients at risk for contrast-induced nephropathy.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  133. WIJNANDS TF, Ronot M, Gevers TJ, Benzimra J, et al
    Predictors of treatment response following aspiration sclerotherapy of hepatic cysts: an international pooled analysis of individual patient data.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  134. FUJITA N, Asayama Y, Nishie A, Ishigami K, et al
    Mass-forming intrahepatic cholangiocarcinoma: Enhancement patterns in the arterial phase of dynamic hepatic CT - Correlation with clinicopathological findings.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


    April 2016
  135. GUIU B, Chevallier P, Denys A, Delhom E, et al
    Simultaneous trans-hepatic portal and hepatic vein embolization before major hepatectomy: the liver venous deprivation technique.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  136. KETELSEN D, Groezinger G, Maurer M, Lauer UM, et al
    Three-dimensional C-arm CT-guided transjugular intrahepatic portosystemic shunt placement: Feasibility, technical success and procedural time.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  137. NERI E, Bali MA, Ba-Ssalamah A, Boraschi P, et al
    ESGAR consensus statement on liver MR imaging and clinical use of liver-specific contrast agents.
    Eur Radiol. 2016;26:921-31.
    PubMed     Text format     Abstract available


  138. HAIMERL M, Schlabeck M, Verloh N, Zeman F, et al
    Volume-assisted estimation of liver function based on Gd-EOB-DTPA-enhanced MR relaxometry.
    Eur Radiol. 2016;26:1125-33.
    PubMed     Text format     Abstract available


    March 2016
  139. ZHOU CG, Chung JW, Hur S, Lee M, et al
    Sectional Localization of a Small Hepatocellular Carcinoma in the Right Hepatic Lobe by Computed Tomography: Comparison between the Conventional and Portal Vein Tracing Methods.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  140. VAN BINNEBEEK S, Vanbilloen B, Baete K, Terwinghe C, et al
    Comparison of diagnostic accuracy of (111)In-pentetreotide SPECT and (68)Ga-DOTATOC PET/CT: A lesion-by-lesion analysis in patients with metastatic neuroendocrine tumours.
    Eur Radiol. 2016;26:900-9.
    PubMed     Text format     Abstract available


  141. VOGL TJ, Schaefer P, Lehnert T, Nour-Eldin NE, et al
    Intraprocedural blood volume measurement using C-arm CT as a predictor for treatment response of malignant liver tumours undergoing repetitive transarterial chemoembolization (TACE).
    Eur Radiol. 2016;26:755-63.
    PubMed     Text format     Abstract available


  142. MERKLE EM, Zech CJ, Bartolozzi C, Bashir MR, et al
    Consensus report from the 7th International Forum for Liver Magnetic Resonance Imaging.
    Eur Radiol. 2016;26:674-82.
    PubMed     Text format     Abstract available


    February 2016
  143. FISCHER MA, Brehmer K, Svensson A, Aspelin P, et al
    Renal versus splenic maximum slope based perfusion CT modelling in patients with portal-hypertension.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  144. HENNEDIGE TP, Hallinan JT, Leung FP, Teo LL, et al
    Comparison of magnetic resonance elastography and diffusion-weighted imaging for differentiating benign and malignant liver lesions.
    Eur Radiol. 2016;26:398-406.
    PubMed     Text format     Abstract available


  145. AMBROSETTI MC, Zamboni GA, Mucelli RP
    Distribution of liver metastases based on the site of primary pancreatic carcinoma.
    Eur Radiol. 2016;26:306-10.
    PubMed     Text format     Abstract available


  146. CHRISTOFIDES D, Leen EL, Averkiou MA
    Improvement of the accuracy of liver lesion DCEUS quantification with the use of automatic respiratory gating.
    Eur Radiol. 2016;26:417-24.
    PubMed     Text format     Abstract available


    January 2016
  147. CHEN Y, Li H, Jiang X, Chen D, et al
    Regional thermochemotherapy versus hepatic arterial infusion chemotherapy for palliative treatment of advanced hilar cholangiocarcinoma: a retrospective controlled study.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  148. LV N, Kong Y, Mu L, Pan T, et al
    Effect of perioperative parecoxib sodium on postoperative pain control for transcatheter arterial chemoembolization for inoperable hepatocellular carcinoma: a prospective randomized trial.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  149. HUANG M, Lin Q, Wang H, Chen J, et al
    Survival benefit of chemoembolization plus Iodine125 seed implantation in unresectable hepatitis B-related hepatocellular carcinoma with PVTT: a retrospective matched cohort study.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  150. FETZER DT, Rees MA, Dasyam AK, Tublin ME, et al
    Hepatic sarcoidosis in patients presenting with liver dysfunction: imaging appearance, pathological correlation and disease evolution.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  151. HINRICHS JB, Shin HO, Kaercher D, Hasdemir D, et al
    Parametric response mapping of contrast-enhanced biphasic CT for evaluating tumour viability of hepatocellular carcinoma after TACE.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  152. FLECKENSTEIN FN, Schernthaner RE, Duran R, Sohn JH, et al
    3D Quantitative tumour burden analysis in patients with hepatocellular carcinoma before TACE: comparing single-lesion vs. multi-lesion imaging biomarkers as predictors of patient survival.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  153. KANG TW, Rhim H, Lee J, Song KD, et al
    Magnetic resonance imaging with gadoxetic acid for local tumour progression after radiofrequency ablation in patients with hepatocellular carcinoma.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  154. HA Y, Lee JB, Shim JH, Kim KM, et al
    Validation and reappraisal of the assessment for retreatment with transarterial chemoembolization score for unresectable non-metastatic hepatocellular carcinoma in a hepatitis b virus-endemic region.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  155. CHOCKALINGAM A, Duran R, Sohn JH, Schernthaner R, et al
    Radiologic-pathologic analysis of quantitative 3D tumour enhancement on contrast-enhanced MR imaging: a study of ROI placement.
    Eur Radiol. 2016;26:103-13.
    PubMed     Text format     Abstract available


  156. WAGNER M, Ronot M, Doblas S, Giraudeau C, et al
    Assessment of the residual tumour of colorectal liver metastases after chemotherapy: diffusion-weighted MR magnetic resonance imaging in the peripheral and entire tumour.
    Eur Radiol. 2016;26:206-15.
    PubMed     Text format     Abstract available


  157. SENDRA L, Perez D, Miguel A, Herrero MJ, et al
    Human AAT gene transfer to pig liver improved by using a perfusion isolated organ endovascular procedure.
    Eur Radiol. 2016;26:95-102.
    PubMed     Text format     Abstract available


    December 2015
  158. KIM YS, Song JS, Lee HK, Han YM, et al
    Hypovascular hypointense nodules on hepatobiliary phase without T2 hyperintensity on gadoxetic acid-enhanced MR images in patients with chronic liver disease: long-term outcomes and risk factors for hypervascular transformation.
    Eur Radiol. 2015.
    PubMed     Text format     Abstract available


    September 2015
  159. KERAMIDA G, Dizdarevic S, Bush J, Peters AM, et al
    Quantification of tumour (18) F-FDG uptake: Normalise to blood glucose or scale to liver uptake?
    Eur Radiol. 2015;25:2701-8.
    PubMed     Text format     Abstract available


    August 2015
  160. YU MH, Lee JM, Hur BY, Kim TY, et al
    Gadoxetic acid-enhanced MRI and diffusion-weighted imaging for the detection of colorectal liver metastases after neoadjuvant chemotherapy.
    Eur Radiol. 2015;25:2428-36.
    PubMed     Text format     Abstract available


  161. WAGNER M, Mariani P, Bidard FC, Rodrigues MJ, et al
    Diffusion-weighted MRI for uveal melanoma liver metastasis detection.
    Eur Radiol. 2015;25:2263-73.
    PubMed     Text format     Abstract available


    July 2015
  162. KIM SH, Kim SH, Kim MA, Shin CI, et al
    CT differentiation of poorly-differentiated gastric neuroendocrine tumours from well-differentiated neuroendocrine tumours and gastric adenocarcinomas.
    Eur Radiol. 2015;25:1946-57.
    PubMed     Text format     Abstract available


  163. CHAPIRO J, Duran R, Lin M, Schernthaner R, et al
    Early survival prediction after intra-arterial therapies: a 3D quantitative MRI assessment of tumour response after TACE or radioembolization of colorectal cancer metastases to the liver.
    Eur Radiol. 2015;25:1993-2003.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: